The addiction field has been waiting 30 years for this

Estimated reading time: 3 minutes

Lancet study shows semaglutide reduced heavy drinking days by 41% in 108 patients with alcohol use disorder.

For 30 years, FDA approved exactly 3 medications for AUD - last one in 1994.

Meanwhile, alcohol kills 178,000 Americans yearly. This is the second positive RCT in a year. Number needed to treat: 4.3 (better than current FDA-approved meds at 7+).

The 30-Year Gap

For three decades, the FDA has approved exactly three medications for alcohol use disorder.

Disulfiram. Acamprosate. Naltrexone.

The newest one was approved in 1994.

Meanwhile, alcohol kills 178,000 Americans every year. Nearly twice the death toll of opioids.

The Study

Published in The Lancet (2026).

108 treatment-seeking patients with moderate-to-severe alcohol use disorder. 26-week, double-blind, placebo-controlled RCT.

Semaglutide 2.4 mg weekly versus saline. Both groups received cognitive behavioral therapy.

Primary outcome: Heavy drinking days reduced by 41%.

Number Needed to Treat: 4.3

That means for every 4.3 patients treated with semaglutide plus CBT versus placebo plus CBT, one additional patient achieves the primary outcome.

Current FDA-approved medications have an NNT of 7 or higher. This is clinically meaningful. This is better than what we currently have.

Beyond Drinking Days

Total alcohol consumption fell 467 grams more per month versus placebo.

Craving scores dropped. Liver enzymes improved. Phosphatidyl ethanol (the gold-standard alcohol biomarker) confirmed the self-reports.

This Isn't the First Signal

Second positive RCT in a year.

Hendershot's JAMA Psychiatry trial showed the same direction in non-treatment-seekers.

Registry studies of 600,000+ patients pointed here first. The signal is consistent across study designs, populations, and outcomes.

Who's Been Waiting

The patient told "you have to want it" because no medication exists for them.

The primary care doctor with nothing to offer between AA and rehab. The family watching a relapse cycle they were told is just willpower.

Alcohol use disorder isn't a personality flaw. It's a treatable brain disease that just got a new tool.

The Bigger Picture

We don't have an opioid crisis instead of an alcohol crisis. We have an addiction crisis.

And we've been treating the smaller half. Alcohol: 178,000 deaths per year. Opioids: ~100,000 deaths per year.

But opioid use disorder has multiple FDA-approved medications. Alcohol use disorder had three… for 30 years.

The Critical Caveat

These are early findings, not definitive proof.

We need larger trials. Longer follow-up. Real-world effectiveness studies. Cost-effectiveness analysis. Mechanisms research.

But it's a signal we haven't had in three decades. A new pharmacological tool for a devastatingly undertreated condition.

Source: The Lancet (2026): Semaglutide for alcohol use disorder

Talk soon,

Bhargav